DJIA 16,956.10 -127.70 -0.75%
NASDAQ 4,447.09 -25.02 -0.56%
S&P 500 1,979.36 -8.62 -0.43%
market minute promo

5.02 -0.03 (-0.59%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PGNX $5.02 -0.59%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.01
Previous Close $5.05
Daily Range $4.96 - $5.10
52-Week Range $3.10 - $7.45
Market Cap $349.2M
P/E Ratio -7.32
Dividend (Yield) $0.00 (0.0%)
Volume 346,267
Average Daily Volume 1,757,228
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Progenics Pharmaceuticals, Inc. (PGNX) Description

A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Website: http://www.progenics.com/

News & Commentary Rss Feed

Why Progenics Pharmaceuticals, Inc. Jumped This Morning

Does this analyst make a good case or is it just more noise from Wall Street?

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

Funds Are Buying These 5 Rallying Stocks Under $5

Progenics-Salix Up on Encouraging Relistor News - Analyst Blog

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape

Morning Market Movers

Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to My

Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to Mylan

Sector Update: Health Care

Benzinga's Top #PreMarket Gainers

What Does A Positive Adcom Mean For Progenics And Salix?

See More PGNX News...

PGNX's Top Competitors

PGNX $5.02 (-0.59%)
Current stock: PGNX
AMGN $122.21 (-0.04%)
Current stock: AMGN
GILD $89.54 (-1.10%)
Current stock: GILD
BIIB $334.44 (-0.70%)
Current stock: BIIB